Abstract: Disclosed is a lubricating oil composition comprising an oil of lubricating viscosity and an oil soluble synergistic mixture of antioxidants, said mixture comprising: a) a hindered amine antioxidant according to formula (I) wherein each R1 is independently selected from a substituted or unsubstituted, branched or linear, C1-C20 hydrocarbyl group; R2 is selected from the group consisting of a hydrogen atom or a, substituted or unsubstituted, branched or linear, C1-C20 hydrocarbyl group; each R3 is independently selected from the group consisting of a hydrogen atom or a, substituted or unsubstituted, branched or linear, C1-C20 hydrocarbyl group; each R4 is independently selected from the group consisting of a hydrogen atom or a, substituted or unsubstituted, branched or linear, C1-C20 hydrocarbyl group; n is an integer from 1 to 4; and m is an integer from 1 to 5; and b) a molybdenum succinimide complex.

Abstract: A composition contains (A) a hydrosilylation reaction catalyst and (B) an aliphatically unsaturated compound having an average, per molecule, of one or more aliphatically unsaturated organic groups capable of undergoing hydrosilylation reaction. The composition is capable of reacting via hydrosilylation reaction to form a reaction product, such as a silane, a gum, a gel, a rubber, or a resin. Ingredient (A) contains an iron-organosilicon ligand complex that can be prepared by reacting an iron carbonyl compound and an organosilicon ligand.

Abstract: It is an object to provide a maleimide-based compound having excellent photoelectric conversion characteristics, and a tautomer or a stereoisomer thereof, a dye for photoelectric conversion, a semiconductor electrode, a photoelectric conversion element, and a photoelectrochemical cell. In order to accomplish the above-described objects, a dye for photoelectric conversion including at least one compound represented by the following general formula (1) is provided. (In the formula (1), R1 represents a direct bond, or a substituted or unsubstituted alkylene group. X represents an acidic group. D represents an organic group containing an electron-donating substituent. Z represents a linking group that has at least one hydrocarbon group selected from aromatic rings or heterocyclic rings).

Abstract: The invention addresses a problem of purifying a monomer to be a precursor according to a simpler and milder method so as to obtain a polymer having a higher molecular weight. The invention relates to a method for producing a condensed polycyclic aromatic compound having n active groups (wherein n is an integer of 1 or more and 4 or less), which comprises bringing a composition containing the condensed polycyclic aromatic compound and a solvent into contact with zeolite.

Abstract: A detectable taggant is described. The detectable taggant may include at least one nano-antenna having a resonant frequency of about 300 GHz to about 800 THz. The nano-antenna is adapted to be physically or chemically associated with an article of manufacture.

Abstract: The invention is directed to an oil soluble additive composition prepared by a process comprising reacting a molybdenum component; an imide derived from the reaction product of a hydrocarbyl dicarboxylic acid component and a polyamine component wherein the hydrocarbyl dicarboxylic acid component is the reaction product of a dicarboxylic acid component and a hydrocarbyl component; and a post-treating agent, thereby producing a post-treated molybdated succinimide additive composition.

Abstract: Embodiments of the invention are directed to Ge comprising heterocyclic compounds which can be used for the preparation of homopolymers and copolymers. The copolymers can be donor-acceptor (DA) alternating copolymers where the donor unit is a Ge comprising heterocyclic unit. The polymers can be used as materials in solar cells and other photovoltaic devices, transistors, diodes, light emitting devices (LEDs), conductors, supercapacitors, batteries, and electrochromic devices.

Abstract: Disclosed is a product prepared by the process for preparing a molybdated succinimide complex, the process comprising: (a) reacting an alkyl or alkenyl succinimide of a polyamine of formula I or formula II or mixtures thereof: wherein R is an about C12 to C30 alkyl or alkenyl group, R? is a straight or branched-chain alkylene group having 2 to 3 carbon atoms, x is 1 to 11, and y is 1 to 10, with an ?,?-unsaturated mono-carboxylic acid or carboxylic acid ester, in a charge mole ratio of the ?,?-unsaturated mono-carboxylic acid or carboxylic acid ester to the succinimide of formula I or formula II or mixtures thereof of about 0.1:1 to about 6:1, and wherein the reaction temperature is no greater than about 135° C.; and (b) reacting the succinimide product of step (a) with an acidic molybdenum compound to provide the molybdated succinimide complex, wherein the molybdated succinimide complex prepared is a liquid at room temperature.

Abstract: The invention relates to novel compositions of 1,3-disubstituted ferrocenes useful for the modification of electrodes.

Abstract: Novel polymeric rhodium catalysts having repeating subunits of Formula (I), wherein R1-R8, X, A, m, n and p are as defined in the application, are described along with methods of using these catalysts, as well as precursors therefor, in the chemical synthesis transformations.

Abstract: The present invention relates to a compound having formula (I): wherein: X is in particular 125I Or 211At; R1 and R?1 are independently from each other chosen preferably from the group consisting of electron-withdrawing groups and alkyl groups; R2 is chosen from the group consisting of: H, alkyl groups, functional groups being able to bind a vector, and functional groups having targeting properties which make the compound of the invention a vector itself; Z is a heteroatom, R5, R8 and R9 are preferably H; Y is preferably an electron withdrawing group.

Abstract: Disclosed is a process for preparing a molybdated succinimide complex, the process comprising: (a) reacting an alkyl or alkenyl mono- or bis-succinimide of a polyamine of formula I or formula II or mixtures thereof: wherein R is an alkyl or alkenyl group having a number average molecular weight of about 500 to about 5,000, R? is a straight or branched-chain alkylene group having 2 to 3 carbon atoms, x is 2 to 11, and y is 1 to 10, with an ?,?-unsaturated mono-carboxylic acid or carboxylic acid ester, in a charge mole ratio of the ?,?-unsaturated mono-carboxylic acid or carboxylic acid ester to the succinimide of formula I or formula II or mixtures thereof of greater than 1.05:1 to about 6:1, and wherein the reaction temperature is in the range of from greater than 80° C. to no greater than about 150° C.

Abstract: Disclosed is a process for preparing a molybdated succinimide complex, the process comprising: (a) reacting an alkyl or alkenyl succinimide of a polyamine of formula I or formula II or mixtures thereof: wherein R is an about C12 to C30 alkyl or alkenyl group, R? is a straight or branched-chain alkylene group having 2 to 3 carbon atoms, x is 1 to 11, and y is 1 to 10, with an ?,?-unsaturated mono-carboxylic acid or carboxylic acid ester, in a charge mole ratio of the ?,?-unsaturated mono-carboxylic acid or carboxylic acid ester to the succinimide of formula I or formula II or mixtures thereof of about 0.1:1 to about 6:1, and wherein the reaction temperature is no greater than about 135° C.; and (b) reacting the succinimide product of step (a) with an acidic molybdenum compound to provide the molybdated succinimide complex, wherein the molybdated succinimide complex prepared is a liquid at room temperature.

Abstract: A molybdated succinimide complex is disclosed which is prepared by a process comprising (a) reacting an alkyl or alkenyl succinimide of a polyamine of formula I wherein R is an about C12 to about C30 alkyl or alkenyl group; a and b are independently 2 or 3, and x is 0 to 10, with an ethylenically unsaturated carboxylic acid or anhydride thereof; and (b) reacting the product of step (a) with an acidic molybdenum compound. Also disclosed is a lubricating oil composition containing at least (a) a major amount of a base oil of lubricating viscosity and (b) a minor amount of the molybdated succinimide complex.

Abstract: A molybdated succinimide complex is disclosed which is prepared by a process comprising (a) reacting a succinimide of a polyamine of formula I: wherein R is a hydrocarbon radical having a number average molecular weight of about 500 to about 5,000, a and b are independently 2 or 3, and x is 0 to 10, with an ethylenically unsaturated carboxylic acid or anhydride thereof, in a charge mole ratio of the ethylenically unsaturated carboxylic acid or anhydride thereof to the succinimide of formula I of about 0.9:1 to about 1.05:1; and (b) reacting the succinimide product of step (a) with an acidic molybdenum compound. Also disclosed is a lubricating oil composition containing at least (a) a major amount of a base oil of lubricating viscosity and (b) a minor amount of the molybdated succinimide complex.

Abstract: Methods of forming a cobaltocenium-containing polymer are provided through polymerizing a plurality of cobaltocenium-containing monomers via controlled radical polymerization or controlled ring-opening polymerization. Each cobaltocenium-containing monomer comprises a cobaltocenium moiety covalently connected to a polymerizable group. Cobaltocenium-containing monomers are also provided that include a cobaltocenium moiety covalently connected to a polymerizable group. Cobaltocenium-containing polymers are also generally provided, such as the polymers formed according to any of the methods or from any of the monomers discussed herein. Methods are also generally provided for exchanging an anion associated with a cobaltocenium side group of a cobaltocenium-containing polymer with a new anion.

Abstract: A molybdated succinimide complex is disclosed which is prepared by a process comprising (a) reacting an alkyl or alkenyl succinimide of a polyamine of formula I wherein R is an about C12 to about C30 alkyl or alkenyl group; a and b are independently 2 or 3, and x is 0 to 10, with an ethylenically unsaturated carboxylic acid or anhydride thereof; and (b) reacting the product of step (a) with an acidic molybdenum compound. Also disclosed is a lubricating oil composition containing at least (a) a major amount of a base oil of lubricating viscosity and (b) a minor amount of the molybdated succinimide complex.

Abstract: A molybdated succinimide complex is disclosed which is prepared by a process comprising (a) reacting a succinimide of a polyamine of formula I: wherein R is a hydrocarbon radical having a number average molecular weight of about 500 to about 5,000, a and b are independently 2 or 3, and x is 0 to 10, with an ethylenically unsaturated carboxylic acid or anhydride thereof, in a charge mole ratio of the ethylenically unsaturated carboxylic acid or anhydride thereof to the succinimide of formula I of about 0.9:1 to about 1.05:1; and (b) reacting the succinimide product of step (a) with an acidic molybdenum compound. Also disclosed is a lubricating oil composition containing at least (a) a major amount of a base oil of lubricating viscosity and (b) a minor amount of the molybdated succinimide complex.

Abstract: The present invention relates to the use of new and known maleimide salts for controlling phytopathogenic fungi, and also to methods for controlling phytopathogenic fungi in crop protection, in the household and hygiene sectors and in materials protection, and also to crop protection compositions comprising these maleimide salts.

Abstract: This invention is concerned with biocompatible magnetic nanocrystals highly soluble and dispersible in a physiological buffer, powder of biocompatible magnetic nanocrystals and nanocrystals bearing surface reactive N-hydroxysuccinimide ester moiety, and preparations thereof. The magnetic nanocrystals in powder form are highly soluble in a physiological buffer. The resultant aqueous colloidal solution presents long term stability in ambient conditions. Moreover, the carboxyl group on the surface of the magnetic nanocrystals can be converted to N-hydroxysuccinimide ester moiety in an organic solvent. The resultant powder of the magnetic nanocrystals carrying surface N-hydroxysuccinimide ester moiety is soluble and dispersible in an aqueous solution. Different types of biomolecules bearing amino group can covalently be attached to the magnetic nanocrystal simply by mixing them in aqueous solutions.

Abstract: The invention is directed to oil soluble additive compositions, lubricating oil compositions derived from a process for preparing a sulfurized oil soluble molybdenum complex having reduced active sulfur comprising: reacting an acidic molybdenum compound with an amide derived from a carboxylic acid component an polyamine component in a ratio from 2:1 to 1:1; there after sulfurizing to provide a sulfurized oil soluble molybdenum which is subsequently treated with at least one compound capable of reacting with the active sulfur of step b).

Abstract: Ferromagnetic multi-block copolymers of the sort which can be used to provide high-density, highly ordered thin films, composites and related articles.

Abstract: Described herein are prostate specific membrane antigen (PSMA) binding conjugates that are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein are pharmaceutical composition containing them and methods of using the conjugates and compositions. Also described are processes for manufacture of the conjugates and the compositions containing them.

Abstract: The present invention relates to a method for the preparation of a functionalized nano size transition metal oxide or sulfide particle comprising the steps of (a) providing a ternary solvent system comprising a polar solvent, a non-polar solvent and an intermediate solvent allowing miscibility of all three components; (b) providing a mixture of a transition metal salt and a ternary solvent; (c) providing a mixture of a suitable source of oxide or sulfide and the ternary solvent; (d) providing a mixture of a non-polar end capping agent and the non-polar solvent; (e) mixing the mixtures; and (f) recovering the resultant functionalized nano size transition metal oxide or sulfide particle. The invention further relates to non-polar end capped nano sized transition metal oxide or sulfide particle so produced and the use of such particles.

Abstract: An oxidizing agent useful for oxidative polymerization of high conductive polymers is provided. This oxidizing agent is a kind of organic metal complex formed of metal ion salts having oxidizing capability and nitrogen-containing compound having lone pair electrons with partial ?-electron character. This organic metal complex has weak oxidizing strength for monomers at room temperature. As such, a mixture of the organic metal complex and the monomers has long-term stability under room temperature. While, at a high temperature, the organic metal complex provides proper oxidative polymerization capability for the monomers. The conductive polymers synthesized by the organic metal complex have excellent conductivity.

Abstract: A molybdated succinimide complex is disclosed which is prepared by a process comprising (a) reacting a succinimide of a polyamine of formula I: wherein R is a hydrocarbon radical having a number average molecular weight of about 500 to about 5,000, a and b are independently 2 or 3, and x is 0 to 10, with an ethylenically unsaturated carboxylic acid or anhydride thereof, in a charge mole ratio of the ethylenically unsaturated carboxylic acid or anhydride thereof to the succinimide of formula I of about to about 1.05:1; and (b) reacting the succinimide product of step (a) with an acidic molybdenum compound. Also disclosed is a lubricating oil composition containing at least (a) a major amount of a base oil of lubricating viscosity and (b) a minor amount of the molybdated succinimide complex.

Abstract: A molybdated succinimide complex is disclosed which is prepared by a process comprising (a) reacting an alkyl or alkenyl succinimide of a polyamine of formula I wherein R is an about C12 to about C30 alkyl or alkenyl group; a and b are independently 2 or 3, and x is 0 to 10, with an ethylenically unsaturated carboxylic acid or anhydride thereof; and (b) reacting the product of step (a) with an acidic molybdenum compound. Also disclosed is a lubricating oil composition containing at least (a) a major amount of a base oil of lubricating viscosity and (b) a minor amount of the molybdated succinimide complex.

Abstract: The application discloses metallized chelator complexes and uses of metallized chelator complexes for dissolving ?-sheet proteins and reducing formation of ?-sheet proteins, where the metallized chelator complex comprises a metal ion chelator and a metal ion.

Abstract: Fluorine-18-labelled maleimide compounds of general formula (I): in which: m represents an integer from 0 to 10; n represents an integer from 1 to 10; Y represents a group selected from optionally substituted monocyclic or bicyclic heterocyclic groups; X represents a radical of formula: (U)a—((CR1R2)b—(V)c)d—((CR3R4)e—(W)f)g— ?in which: a, b, c, d, e, f and g represent each independently an integer from 0 to 10; U, V and W represent each independently —NR1—, —O—, —S—, ?ethynyl, —CR1?CR2—, —(C?O)—, —(C?S)—, —C(?NR1)—, —C(?O)O—, —(C?S)S—, —C(?NR1)NR2—, —CR1R2—, —CR1OR2— or —CR1NR2R3—. Process for preparing these compounds; their use for labelling macromolecules, and complexes of these compounds with a macromolecule. Detection and analysis kit, or diagnosis kit, comprising the said complexes. Use of the complexes in a medical imaging process such as positron emission tomography (PET).

Abstract: The present invention is based on new ligand systems of the general formula (I). These ligand systems can be used advantageously in transition metal-catalysed asymmetric syntheses. Likewise encompassed are the transition metal complexes thus prepared, a process for preparing the ligands and the use of the complexes in asymmetric synthesis.

Abstract: Disclosed are compounds having the following formula: in which Z11 is selected from a substituted or unsubstituted saturated adamantyl or other polycyclic group and a substituted or unsubstituted branched acyclic group containing at least 5 carbon atoms at least one of which is a tertiary carbon; and in which Z12 is a cyclic imide. Methods of using these compounds as chiral catalysts for carbenoid reactions and for enantioselective C—H aminations are also described.

Abstract: Novel amides and imides are inhibitors of tumor necrosis factor&agr; and phosphodiesterase and can be used to combat cachexia, endotoxic shock, retrovirus replication, asthma, and inflammatory conditions.

Abstract: Novel metal salts of (poly)citraconimide and (poly)itaconimide carboxylic acids, and a vulcanizable rubber composition comprising these novel metal salts and which, upon vulcanization, exhibits improved dynamic properties, are disclosed. Also disclosed are a sulfur-vulcanization process carried out in the presence of these metal salts and the product of said vulcanization process. The novel metal salts are represented by the formulas I and II: ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are independently selected from hydrogen, C.sub.1 -C.sub.18 alkyl groups, C.sub.3 -C.sub.18 cycloalkyl groups, C.sub.6 -C.sub.18 aryl groups, C.sub.7 -C.sub.30 aralkyl groups and C.sub.7 -C.sub.30 alkaryl groups and R.sub.2 and R.sub.3 may combine to form a ring when R.sub.1 is hydrogen; R.sub.4 is selected from divalent, trivalent or tetravalent linear or branched radical chosen from a C.sub.1 -C.sub.18 alkyl, C.sub.2 -C.sub.18 alkenyl, C.sub.2 -C.sub.18 alkynyl, C.sub.3 -C.sub.18 cycloalkyl, C.sub.3 -C.sub.

Abstract: Pharmaceutical compounds of the formula ##STR1## in which n is 0, 1 or 2 and R.sup.1 is attached at any of the positions 7, 8, 9 or 10, and each R.sup.1 is halo, carboxy, trifluoromethyl, hydroxy, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, C.sub.1-4 alkylthio, hydroxy-C.sub.1-4 alkyl, hydroxy-C.sub.1-4 alkoxy, nitrogen-containing heterocyclyl, nitro, trifluoromethoxy, --COOR.sup.5 where R.sup.5 is an ester group, --COR.sup.6, --CONR.sup.6 R.sup.7 or --NR.sup.6 R.sup.7 where R.sup.6 and R.sup.7 are each hydrogen or C.sub.1-4 alkyl;R.sup.2 is phenyl, naphthyl or heteroaryl selected from thienyl, pyridyl, benzothienyl, quinolinyl, benzofuranyl or benzimidazolyl, said phenyl, naphthyl and heteroaryl groups being optionally substituted, or R.sup.2 is furanyl optionally substituted with C.sub.1-4 alkyl;R.sup.3 is nitrile, carboxy, --COOR.sup.8 where R.sup.8 is an ester group, or --CONR.sup.9 R.sup.10 where R.sup.9 and R.sup.10 are each hydrogen or C.sub.1-4 alkyl; andR.sup.4 is --NR.sup.11 R.sup.12, --NR.sup.11 COR.sup.

Abstract: A transition metal organometallic compound comprising a transition metal in any one of group 3A to group 8 of the periodic table and cyclic compounds containing a heteroaom in group 5 or group 5B of the periodic table and having a cyclic structure including a .pi.-bonded portion and composed of said heteroatom and said .pi.-bonded portion, wherein said transition metal has a bond of a .pi.-binding heterocylic ligand, said heteroatom and said .pi.-bonded portion and a catalyst for polymerizing olefin comprising the above organic metal compound and an organic compound.

Abstract: Methods of treating an immune disease, cell proliferation, restenosis and vascular smooth muscle cells using the pharmaceutical compounds of the formula ##STR1## in which R.sup.2 is phenyl, naphthyl or heteroaryl selected from thienyl, pyridyl, benzothienyl, quinolinyl, benzofuranyl or benzimidazolyl, said phenyl, naphthyl and heteroaryl groups being optionally substituted, or R.sup.2 is furanyl optionally substituted with C.sub.1-4 alkyl; and salts thereof.

Abstract: Use of biscationic acid imide and acid imide derivatives whose anion is the stoichiometric equivalent of one or more organic or inorganic, mixed or non-mixed anions, the compounds also being able to exist as mixed crystals with different cations, individually or in combination, as charge controllers for toners and developers employed for electrophotographic copying or multicopying of originals and for printing electronically, optically or magnetically stored data or in color proofing, and as charge controllers for powders and powder paints.

Abstract: Compositions containing(a) at least one 1,4-diketopyrrolo[3,4-c]pyrrole of the formula I, II, IIa, III or IV ##STR1## and (b) an auxiliary redox system from the ferrocyanide, ferrocene or ammonium iron (II) sulfate series in combination with at least one conductive salt (c), where, in the formula I,R and R.sub.2 are, for example, --H and R.sub.1 is --SO.sub.3 Na,in the formulae II and IIa, R and R.sub.3 are, for example, --H, R.sub.1 is --SO.sub.3 H and p is 3,in the formula III, R.sub.4 and R.sub.5 are, for example, phenyl and R.sub.6 and R.sub.7 are, for example, methyl, andin the formula IV R.sub.8 and R.sub.9 are, for example, phenyl,are suitable as electrochromic materials in display systems.

Abstract: Flameproofed compositions of matter include an organic synthetic resin and, as a flame retardant therefor, an effective flameproofing amount of specified nitrogenous/halometallic compounds, certain of which are per se novel.

Abstract: Heteropolyacid salts of the formula ##STR1## R.sup.1 and R.sup.2 independently of one another stand for hydrogen, chlorine, bromine, hydroxyl, C.sub.1 - to C.sub.4 -alkoxy, nitro or carboxyl,A stand for C.sub.1 - to C.sub.5 -alkylene or --C.sub.6 H.sub.4 --CH.sub.2 -- (m- or p-),m stands for 0 or 1,n stands for 1 or 2,K.sup..sym. stands for ##STR2## R.sup.3 stands for C.sub.1 - to C.sub.24 -alkyl, carbamoyl-C.sub.1 - to C.sub.2 -alkyl, C.sub.1 - to C.sub.4 -alkoxycarbonyl-C.sub.1 - to C.sub.2 -alkyl, benzyl, cyclohexyl or allyl,R.sup.4 stands for C.sub.1 - to C.sub.4 -alkyl or a single bond linked to D,R.sup.5 stands for C.sub.1 - to C.sub.4 -alkyl,D stands for --CH.sub.2 --, --CH.sub.2 --CO--, --CH.sub.2 --CO--NH-- or --CH.sub.2 --CO--NH--CH.sub.2 --,W stands for ##STR3## CO or for single bond, Z stands for --CH.sub.2 --, ##STR4## --O--, --S--, --SO.sub.2 -- or a single bond and X.sup..crclbar.

Abstract: A mercuric maleimide is utilized as a pharmaceutical kit for preparing radiohalogenated maleimides.

Abstract: There are provided compounds of formula I, ##STR1## and pharmaceutically acceptable derivatives thereof. There are also described the use of the compounds of formula I as pharmaceuticals, methods for making the compounds and pharmaceutical, e.g. cardiac, compositions containing the compounds.

Abstract: Disclosed are complexes of bismuth or antimony halides with amines having formula:R.cndot.(MeX.sub.3)y,where R is dicyandiamide, guanamine, 2-guanidinobenz-imidazole, isophoronediamine, piperazine, melamine or a compound having from 2 to 9 triazine rings condensed or linked to each other through at least one --NH-- group; Me is Bi or Sb; X is chlorine or bromine; and y is a number from 0.3 to 4. Processes for preparing the complexes and flame retardant thermoplastic polymer compositions containing the complexes are also disclosed.

Abstract: Novel complexes are prepared from water-soluble compounds having at least one amidocarbonylic unit and a square planar organometallic compound.

Abstract: An oxoquinazoline carbamate of the formula ##STR1## in which R represents hydrogen, alkyl, alkoxy, alkoxyalkyl, alkylthio, alkylthioalkyl, halogenoalkyl or optionally substituted aryl,R.sup.1 represents alkyl,R.sup.2 represents halogenoalkyl,R.sup.3 represents alkyl or halogen andn represents a number from 0 to 4,which possess fungicidal and microbicidal activity.

Abstract: The invention provides various medical compositions for use in treating or preventing certain of the side effects of diabetes or galactosemia. The active ingredients are selected from a series of novel aldose reductase inhibitory spiro-linked pyrrolidine-2,5-diones of the general formula: ##STR1## or a pharmaceutically acceptable salt, or a non-toxic, biodegradable precursor thereof. Processes for the production of these compounds are also provided. A particular compound suitable for use as an active ingredient is spiro[pyrrolidine-3,9'-xanthene]-2,5-dione.

Abstract: Chiral Schiff bases according to the general formula: ##STR1## and transition metal complexes thereof, wherein C.sup.* is an asymmetric carbon atom, R.sup.1 and R.sup.2, which may be the same or different are alkyl, aralkyl, aryl or alkaryl, R.sup.3 is hydrogen, alkyl, aralkyl, aryl or alkaryl, R.sup.4 and R.sup.5, which may be the same or different, are hydrogen or lower alkyl or, where n is 1, may with the cyclic ring to which CR.sup.4 R.sup.

Abstract: Novel high purity crystalline forms of dialkylgermaazaspirodiones, their preparation and their use in an improved process for the preparation of high purity dialkylgermaazaspiranes and their acid addition salts is disclosed.